Scaling up treatments for HIV, tuberculosis and malaria
Grant Value

US$27.7 million

Time frame

2006-2012

Lead Grantee

Global Fund

Program Area
HIV and coinfections
Status: Completed

The problem

The Global Fund is the established mechanism for procuring essential medicines for infectious diseases, with a special focus on HIV, tuberculosis and malaria. Without sustained financial support, people may not be able to access critical medicines when they need them.

Download the project evaluation

Our response

This project aimed to scale up access to treatment and reduce prices of medicines for the treatment of HIV/AIDS, multidrug-resistant tuberculosis (MDR-TB) and malaria through Global Fund grants in round 6, phase 1. The grants enabled the procurement of antiretroviral drugs for HIV, artemisinin-based combination therapies for malaria, and treatments for MDR-TB across more than 30 countries.

Our partner

VISIT WEBSITE